BYSI · XBRL financial data

BeyondSpring financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BYSI's year ends in late December)

In thousands of dollars	Q4 FY18Dec 31, 2018	Q4 FY19Dec 31, 2019	Q4 FY20Dec 31, 2020	Q4 FY21Dec 31, 2021	Q4 FY22Dec 31, 2022	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Research and development	year only	year only	year only	year only	year only	472*	874	1,002	1,039	1,473*	1,076	973
Selling, general and administrative	year only	year only	year only	year only	year only	1,228*	1,736	947	751	1,123*	1,156	758
General and administrative	year only	year only	—	—	—	—	—	—	—	—	—	—
Operating income (loss)	year only	year only	year only	year only	year only	(1,700)*	(2,610)	(1,949)	(1,790)	(2,596)*	(2,232)	(1,731)
Interest income	year only	year only	year only	year only	year only	4*	17	28	19	14*	8	4
Interest expense	—	year only	year only	year only	year only	—	—	—	—	—	—	—
Other income (expense)	year only	year only	year only	year only	year only	—	—	—	—	—	—	—
Income tax expense (benefit)	—	year only	year only	year only	year only	(96)*	20	22	26	22*	192	100
Net income (loss)	year only	year only	year only	year only	year only	(1,729)*	4,477	(1,806)	(1,540)	(2,137)*	(2,159)	(849)
Earnings per share, basic USD per share	—	—	—	—	—	—	0.11	(0.04)	(0.04)	—	(0.05)	(0.02)
Earnings per share, diluted USD per share	—	—	—	—	—	—	—	(0.10)	—	—	—	—
Weighted average shares, basic thousands of shares	—	—	—	—	—	—	40,316	40,316	40,317	—	41,120	41,120

Balance sheet

CSV

Fiscal quarters (BYSI's year ends in late December)

In thousands of dollars	Q4 FY18Dec 31, 2018	Q4 FY19Dec 31, 2019	Q4 FY20Dec 31, 2020	Q4 FY21Dec 31, 2021	Q4 FY22Dec 31, 2022	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	3,889	35,933	109,537	41,625	34,396	2,922	6,527	9,544	12,483	7,786	4,036	2,697
Short-term investments	—	—	0	30,743	2,872	0	2,000	—	141	4,775	3,827	3,832
Prepaid and other current assets	292	410	358	1,020	763	68	90	200	131	71	181	273
Total current assets	5,871	40,862	113,400	75,123	38,523	28,577	31,526	25,711	24,411	20,882	13,504	9,901
Property and equipment, net	282	209	184	1,422	1,868	239	221	202	184	166	152	138
Right-of-use asset	—	2,538	2,174	1,984	5,484	513	492	431	368	305	240	174
Total assets	7,063	44,555	117,038	81,648	46,222	34,315	37,104	31,043	29,484	25,933	18,406	14,606
Accounts payable	9,586	2,537	2,216	1,656	1,081	295	358	266	304	363	646	790
Accrued liabilities	5,495	5,861	5,607	3,858	2,470	840	909	926	990	938	1,278	1,390
Current portion of long-term debt	—	—	0	1,569	0	—	—	—	—	—	—	—
Total current liabilities	16,445	10,053	13,766	15,155	7,352	11,010	12,665	11,730	12,891	13,576	12,370	14,193
Long-term debt	—	1,436	2,167	0	—	—	—	—	—	—	—	—
Lease liability, non-current	—	1,935	1,359	1,468	3,995	307	246	170	93	0	—	—
Total liabilities	16,445	13,424	25,217	55,271	49,229	48,600	49,771	48,588	49,294	49,923	48,760	50,631
Accumulated deficit	(178,760)	(216,845)	(277,818)	(341,997)	(375,276)	(407,425)	(402,948)	(404,754)	(406,294)	(408,431)	(410,590)	(411,439)
Total stockholders' equity	(7,766)	30,277	88,340	26,684	(5,979)	(32,900)	(28,309)	(30,216)	(31,775)	(32,161)	(34,487)	(35,566)
Total liabilities and equity	7,063	44,555	117,038	81,648	46,222	34,315	37,104	31,043	29,484	25,933	18,406	14,606
Common shares outstanding (cover page) thousands of shares	23,185	27,886	39,142	38,928	39,000	40,316	40,316	40,332	40,332	41,120	41,120	41,120

Cash flows

CSV

Fiscal quarters (BYSI's year ends in late December)

In thousands of dollars	Q4 FY18Dec 31, 2018	Q4 FY19Dec 31, 2019	Q4 FY20Dec 31, 2020	Q4 FY21Dec 31, 2021	Q4 FY22Dec 31, 2022	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	year only	year only	year only	year only	year only	(1,729)*	4,477	(1,806)	(1,540)	(2,137)*	(2,159)	(849)
Stock-based compensation	year only	year only	year only	year only	year only	399*	244	145*	166*	167*	461	575*
Net cash from operating activities	year only	year only	year only	year only	year only	982*	(4,198)	(5,874)*	(4,193)*	(5,504)*	(3,277)	(3,772)*
Purchases of property and equipment	year only	year only	year only	year only	year only	27*	50	0*	0*	0*	0	0*
Net cash from investing activities	year only	year only	year only	year only	year only	(9,815)*	6,304	10,850*	(1,220)*	(5,147)*	4,479	(5)*
Proceeds from issuing common stock	year only	year only	year only	year only	year only	0*	—	—	0*	2,000*	—	—
Net cash from financing activities	year only	year only	year only	year only	year only	1,843*	0	0*	2,997*	1,971*	(4,157)	(74)*
Net change in cash	year only	year only	year only	year only	year only	(7,014)*	2,111	4,969*	(2,424)*	(8,565)*	(2,933)	(3,840)*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
BeyondSpring	2,697	not reported	(3,772)*	41.1M	1.7 quarters	Q2 FY26 10-QJun 30, 2026
Corbus Pharmaceuticals Holdings	23,370	not reported	(29,626)*	19.3M	4.0 quarters	Q2 FY26 10-QJun 30, 2026
Seres Therapeutics	15,594	736	(22,394)*	9.9M	0.7 quarters	Q2 FY26 10-QJun 30, 2026
Oncolytics Biotech	4,115	not reported	(8,138)*	127.5M	0.5 quarters	Q2 FY26 10-QJun 30, 2026
Gyre Therapeutics	43,287	29,105	(16,728)*	111.5M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Volitionrx	2,800	399	(5,160)*	13.6M	0.5 quarters	Q2 FY26 10-QJun 30, 2026
Macrogenics	113,907	32,832	(40,748)*	63.7M	2.8 quarters	Q2 FY26 10-QJun 30, 2026
Inovio Pharmaceuticals	31,526	0	(18,047)*	103.4M	2.0 quarters	Q2 FY26 10-QJun 30, 2026
Whitehawk Therapeutics	85,234	0	(14,529)*	57.0M	13.1 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.